These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 1442067
1. [Effects erythropoietin on experimental anemia in rats with chronic renal failure]. Ling SS, Zhou Y, Sun WL, Zhu DC, Zhang HY, Tang GZ, Jin YF, Zhu JZ. Yao Xue Xue Bao; 1992; 27(6):412-7. PubMed ID: 1442067 [Abstract] [Full Text] [Related]
2. Effect of chronic renal failure on the expression of erythropoietin message in a murine model. Zhang F, Laneuville P, Gagnon RF, Morin B, Brox AG. Exp Hematol; 1996 Nov; 24(13):1469-74. PubMed ID: 8950229 [Abstract] [Full Text] [Related]
5. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency]. Dimković N. Med Pregl; 2001 Nov; 54(5-6):235-40. PubMed ID: 11759218 [Abstract] [Full Text] [Related]
8. Biological characterization of recombinant human erythropoietin. Krumwieh D, Arnold I, Seiler FR. Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225 [Abstract] [Full Text] [Related]
9. Erythropoietic action of dexamethasone on the anemia associated with an experimental chronic renal failure. Malgor LA, Barrios L, de Albarenque MV, Verges E, de Markowsky EE, Montiel E, Mussin SM. Acta Physiol Pharmacol Latinoam; 1987 Aug; 37(3):365-76. PubMed ID: 3503475 [Abstract] [Full Text] [Related]
10. Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene. Oh TK, Quan GH, Kim HY, Park F, Kim ST. Am J Nephrol; 2006 Aug; 26(4):326-34. PubMed ID: 16825758 [Abstract] [Full Text] [Related]
15. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis]. Canaud B, Polito-Bouloux C, Rivory JP, Donnadieu P, Taib J, Florence P, Mion C. Nephrologie; 1990 Aug; 11(1):5-10. PubMed ID: 2374643 [Abstract] [Full Text] [Related]
16. Interrelationship between erythropoietin and erythropoiesis: insights from renal transplantation. Lee DB. Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):54-6. PubMed ID: 1928080 [Abstract] [Full Text] [Related]
17. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity. Bajo MA, Selgas R, Miranda B, Fernandez-Zamorano A, Borrego F, Romero JR, Caparros G, Riñon C, Sanchez Sicilia L. Adv Perit Dial; 1991 Oct; 7():296-300. PubMed ID: 1680450 [Abstract] [Full Text] [Related]
18. [Effect of recombinant human erythropoietin administration on cardiovascular system in patient with chronic renal failure: an analysis of the blood pressure upward]. Satoh K, Ikeda Y, Kurokawa S, Kamata K, Masuda T, Kikawada R, Marumo F. Kokyu To Junkan; 1989 Mar; 37(3):313-9. PubMed ID: 2734509 [Abstract] [Full Text] [Related]
19. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N, Osman-Malik Y, Frinak S, Besarab A. Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [Abstract] [Full Text] [Related]
20. Potential for erythropoietin synthesis in kidney of uraemic rat alters depending on severity of renal failure. Sanada S, Toyama H, Ejima Y, Matsubara M. Nephrology (Carlton); 2009 Dec; 14(8):735-42. PubMed ID: 20025682 [Abstract] [Full Text] [Related] Page: [Next] [New Search]